Interpreting evidence in general practice Bias and conflicts of Interest

被引:6
|
作者
Parker, Lisa [1 ,2 ]
Grundy, Quinn [1 ,2 ]
Bero, Lisa [1 ,2 ]
机构
[1] Charles Perkins Ctr, Camperdown, NSW, Australia
[2] Univ Sydney, Sch Pharm, Sydney, NSW, Australia
关键词
RANDOMIZED CONTROLLED-TRIALS; PHARMACEUTICAL-INDUSTRY; QUALITY; RISKS;
D O I
10.31128/AJGP-12-17-4432
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background Sponsorship of research and education occurs commonly in the pharmaceutical, medical device, and food and drink industries. This sponsorship is a conflict of interest, creating a situation where there may be bias in favour of the sponsors' interests. General practitioners (GPs) need to be aware of potential conflicts of interest in industry-sponsored research and education. Objectives The aim of this article is to alert GPs to the risk of bias in research and education funded by for-profit organisations, and to provide strategies to avoid being influenced by information that may be biased. Discussion Types of bias known to be associated with industry sponsorship include: methodological bias, where there is a systematic error in the design, conduct or analysis of the study such that it deviates from the truth; agenda bias, where study topics align with increased use of industry products; publication and reporting bias, where unfavourable studies or results are suppressed or omitted; and marketing bias, where supportive evidence is preferentially disseminated and sympathetic opinion leaders are given a broad platform. Industry influence can be reduced by seeking out independent reviews and avoiding industry-funded educational events.
引用
收藏
页码:337 / 340
页数:4
相关论文
共 50 条
  • [41] Systematic review: the quality of the scientific evidence and conflicts of interest in international inflammatory bowel disease practice guidelines
    Feuerstein, J. D.
    Akbari, M.
    Gifford, A. E.
    Cullen, G.
    Leffler, D. A.
    Sheth, S. G.
    Cheifetz, A. S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 37 (10) : 937 - 946
  • [42] Conflicts of Interest, Disclosure, and (Costly) Sanctions: Experimental Evidence
    Church, Bryan K.
    Kuang, Xi
    JOURNAL OF LEGAL STUDIES, 2009, 38 (02): : 505 - 532
  • [43] Bias: Linking Evidence With Practice
    Kamper, Steven J.
    JOURNAL OF ORTHOPAEDIC & SPORTS PHYSICAL THERAPY, 2018, 48 (08): : 667 - 668
  • [44] Conflicts of Interest in Clinical Practice: Cleveland Clinic Policy and Experience
    Derwin, Kathleen A.
    Anand, Cory
    Rose, Susannah L.
    Dweik, Raed
    JOURNAL OF LAW MEDICINE & ETHICS, 2024, 52 (03): : 734 - 742
  • [45] Continuing Problems With Financial Conflicts of Interest and Clinical Practice Guidelines
    DeJong, Colette
    Steinbrook, Robert
    JAMA INTERNAL MEDICINE, 2018, 178 (12) : 1715 - 1715
  • [46] Addressing Potential Conflicts of Interest in Dermatology Clinical Practice Guidelines
    Lim, Henry W.
    Elmets, Craig A.
    Begolka, Wendy Smith
    JAMA DERMATOLOGY, 2018, 154 (03) : 259 - 260
  • [47] TACKLING CONFLICTS OF INTEREST Conflicts of interest and drug information
    Menkes, David B.
    BRITISH MEDICAL JOURNAL, 2011, 343
  • [48] Conflicts of interest in psychiatry: Strategies to cultivate literacy in daily practice
    Shimazawa, Rumiko
    Ikeda, Masayuki
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2014, 68 (07) : 489 - 497
  • [49] Conflicts of interest in pain medicine: Practice patterns and relationships with industry
    Schofferman, Jerome
    Banja, John
    PAIN, 2008, 139 (03) : 494 - 497
  • [50] Conflict of Interest Blind Spots in Emergency Medicine: Ideological and Financial Conflicts of Interest in the Gender Bias Literature
    Donaldson, Chase M.
    ACADEMIC EMERGENCY MEDICINE, 2019, 26 (11) : 1300 - 1302